precirol has been researched along with sildenafil citrate in 1 studies
| Studies (precirol) | Trials (precirol) | Recent Studies (post-2010) (precirol) | Studies (sildenafil citrate) | Trials (sildenafil citrate) | Recent Studies (post-2010) (sildenafil citrate) |
|---|---|---|---|---|---|
| 81 | 0 | 52 | 5,862 | 956 | 2,319 |
| Protein | Taxonomy | precirol (IC50) | sildenafil citrate (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boraie, N; Makled, S; Nafee, N | 1 |
1 other study(ies) available for precirol and sildenafil citrate
| Article | Year |
|---|---|
Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization.
Topics: A549 Cells; Administration, Inhalation; Animals; Cell Survival; Delayed-Action Preparations; Diglycerides; Drug Carriers; Humans; Hypertension, Pulmonary; Lipids; Male; Nanostructures; Phosphodiesterase 5 Inhibitors; Polyvinyl Alcohol; Rats, Sprague-Dawley; Sildenafil Citrate | 2018 |